To evaluate persistence of immune response to mRNA vaccines in PLWH with advanced disease
Latest Information Update: 29 Mar 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 29 Mar 2022 New trial record
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections